rs752864722
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PVS1PM2PP5
The NM_199069.2(NDUFAF3):c.180_181insT(p.Asp61fs) variant causes a frameshift, stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000044 in 1,612,936 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_199069.2 frameshift, stop_gained
Scores
Clinical Significance
Conservation
Publications
- undetermined early-onset epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- developmental and epileptic encephalopathy, 86Inheritance: AR, Unknown Classification: LIMITED Submitted by: Illumina, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 11 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_199069.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| NDUFAF3 | NM_199069.2 | MANE Select | c.180_181insT | p.Asp61fs | frameshift stop_gained | Exon 2 of 5 | NP_951032.1 | ||
| NDUFAF3 | NM_199070.2 | c.9_10insT | p.Asp4fs | frameshift stop_gained | Exon 2 of 5 | NP_951033.1 | |||
| NDUFAF3 | NM_199073.2 | c.9_10insT | p.Asp4fs | frameshift stop_gained | Exon 2 of 5 | NP_951047.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| NDUFAF3 | ENST00000326925.11 | TSL:1 MANE Select | c.180_181insT | p.Asp61fs | frameshift stop_gained | Exon 2 of 5 | ENSP00000323076.5 | ||
| NDUFAF3 | ENST00000451378.2 | TSL:1 | c.9_10insT | p.Asp4fs | frameshift stop_gained | Exon 2 of 5 | ENSP00000402465.2 | ||
| NDUFAF3 | ENST00000326912.8 | TSL:2 | c.9_10insT | p.Asp4fs | frameshift stop_gained | Exon 2 of 5 | ENSP00000323003.4 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152206Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000101 AC: 25AN: 248112 AF XY: 0.000104 show subpopulations
GnomAD4 exome AF: 0.0000445 AC: 65AN: 1460730Hom.: 0 Cov.: 32 AF XY: 0.0000468 AC XY: 34AN XY: 726684 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152206Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74352 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge
Mitochondrial complex I deficiency Uncertain:1
The p.Asp61X variant in NDUFAF3 has not been previously reported in individuals with mitochondrial complex I deficiency, but has been identified in 0.02% (2/8250) of European American chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/). This nonsense variant leads to a premature termination codon at position 61, which is predicted to lead to a truncated or absent protein. While complete loss of NDUFAF3 function has been described in a several individuals with mitochondrial complex I deficiency (Saada 2009), the gene-disease association has not been fully established. In summary, while there is some suspicion for a pathogenic role, the clinical significance of the p.Asp61X variant is uncertain.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at